< Study report on Probiotics (For Human) >
|
Section I: Bacterial Diarrhea |
|
1. Inhibition of growth of some Enteropathogenic strains in mixed culture of Streptococcus faecalis and Clostridium butyricum
|
- Microbios Letters; 40, 151-180, 1989
|
|
2. Growth of other bacteria with symbiosis of Streptococcus faecalis and Clostridium butyricum in the continuous flow culture system
|
- Tokyo University of Pharmacy; 1986
|
|
3. Inhibitory action of Streptococcus faecalis and Clostridium butyricum against enterohemorrhagic E.coli (E.coli O-157) in the continuous flow culture
|
- Iyaku-no-mon; Vol. 31, No. 3, 1991
|
|
4. A case having succeeded in eliminating drug resistant Salmonella by the administration of a live bacterial preparation
|
- Medicine & Pharmaceutical Science; 29 (4), 1027-1030, 1993
|
|
5. Clinical result of the intestinal remedy (BIO-THREE®) containing three live bacteria species for bacterial diarrhea
|
- Progress in Medicine; Vol. 13, No. 3, 1993
|
|
6. Inhibition of Methicillin-Resistant Staphylococcus aureus (MRSA) in the continuous flow culture system to Streptococcus faecalis and Clostridium butyricum
|
- Iyaku-no-Mon; Vol. 33 (2), 71-74, 1993
|
|
7. Studies on microbiological characteristics in Enterococus preparations
|
- Japanese Journal of Pharmaceutical Health Care and Sciences; Vol. 19, No. 4, 1993
|
|
8. Estimation of Probiotics by infection model of infant rabbit with Enterohemorrhagic Escherichia coli O157: H7
|
- Journal of the Japanese Association for Infectious Disease, 1300-1305, 1998
|
|
9. Probiotics have clinical, microbiologic and immunologic efficacy in acute infectious diarrhea
|
- The Pediatric Infectious Disease Journal; Vol. 29, No. 2, 2010
|
|
Section II: Abnormal Bowel Movement |
|
1. Clinical report of treating Abnormal Bowel Movement by BIO-THREE
|
- Iyaku-no-Mon; 29 (4), 221-224, 1989
|
|
2. Clinical records using BIO-THREE combined with other medication to treat various symptoms of Irritable Bowel Syndrome
|
- Diagnosis and Therapy; 80 (supple) 702-704, 1992
|
|
3. Effect of administration of BIO-THREE on abnormal bowel movement from endocrine and rheumatic diseases
|
- Medicine & Pharmaceutical Science; 31 (5), 1483-1487, 1994
|
|
Section III: Neonatal Infection |
|
1. Nutrition Management on Low Birth Weight Infants with Infection
|
- JJPEN, Vol. 21, No. 2, 1999
|
|
2. Does Probiotics administration decrease Serum Endotoxin levels in infants?
|
- Journal of Paediatric Surgery; No. 34, No. 2 (Feb), 273-276, 1999
|
|
3. A review of Neonatal Infection in the NICU
|
- Shusanki Igaku; Vol. 30, No. 12, 2000
|
|
Section IV: Others |
|
1. Stimulation of bacterial growth of some strains of Bifidobacterium by a crude preparation of metabolites from Bacillus mesentericus TO-A
|
- Biomedical Letters; 48, 73-78, 1993
|
|
2. The effects of a division-promoting factor for Bifidobacterium produced by Bacillus mesentericus on bacterial flora in the rat caecum
|
- Microbios; 80, 49-53, 1994
|
|
3. Characterization of Enterococcus strains contained in Probiotics products
|
- Biol. Pharm. Bull.; 34 (9) 1469-1473, 2011
|
|
4. Probiotics reduce infectious complications after Pancreaticoduodenectomy
|
- Hepato-Gastroenterology; 54, 2007
|
|
5. Clinical effectiveness of Probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy
|
- Scandinavian Journal of Gastroenterology; 42, 1306-1311, 2007
|
|
6. Clostridium butyricum TO-A culture supernatant down-regulates TLR in human colonic epithelial cells
|
- Dig Dis Sci.; 52, 2963-2971, 2007
|
|
7. Effects of Probiotics on the bacterial translocation in patients with schizophrenia
|
- Nippon Mibyo System Gakkai Zasshi; 10 (2), 237-244, 2004
|
|
< Study report on Probiotics (For Livestock) >
|
|
1. Effects of feeding Probiotics on the localization of cells containing immunoreactive Interleukin-6 in the intestine of broiler chicks
|
- Japan Poultry Science; 47, 250-255, 2010
|
|
2. Effects of low dose "BIO-THREE Ace" administered to Japanese black-furred fattening cattle
|
- Presented at the meeting of Japan Veterinary Association in Kyushu district; November 2004
|
|
3. Effects of BIO-THREE administered for the purpose of preventing pigletfs disease and improving the fattening outcome in growing-finishing pigs
|
- Presented at the meeting of Japan Veterinary Association in Kyushu district; November 2006
|
|
4. Pigletfs growth test by feeding of "BIO-THREE PZ", an organic zinc-added probiotics
|
- SPF pig farm, Hakuba; 2006
|
|
Remarks: For further information, please contact us |